Keywords: Allogeneic; Allotransplant; CIBMTR; Center for International Blood and Marrow Transplant Research; DLI; Donor lymphocyte infusion; EBMT; European Group for Blood and Marrow Transplant; HCT; Hematopoietic cell transplantation; Leukemia; Second transplant;